• About
    • Our Mission & Vision
    • Quality Policy
    • Export
  • Investor's Information
    • Price Sensitive Information
    • Annual/Auditor's Reports
    • Unaudited Reports
    • Director's Report
    • Profile Of Directors
    • Board of Directors & Top Management
    • Nature of Business of JSMD
    • Shareholding Composition
    • Info. Of Investor Relation Department
    • Notice & General Information
    • Credit Rating Reports
    • Corporate Governance
    • Appointment of MD, CEO, CFO
    • Duties & Responsibilities of Mgmt
    • Link DSE CSE
    • Dividend Policy
    • Dividend Distribution Compliance Report
    • Unpaid Dividend
    • Code of Conduct
  • Major Highlights
  • Products
    • AD Syringes
    • Disposable Syringes
    • Toomey Syringe
    • Insulin Syringes
    • Disposable Needles
    • Spinal Needle
    • Scalp Vein Set
    • IV Infusion Set
    • I.V. Cannula
    • Blood Transfusion Set
    • First Aid Bandage
    • Urine Drainage Bag
    • JMI Leg Bag
    • JMI Nelaton Catheter
    • JMI Disposable Stomach Tube
    • JMI Umbilical Cord Clamp
    • Wound Drain Tube
    • Feeding Tube
    • JMI Oral Dispenser
    • Suction Catheter
    • 3-Way Stopcock
    • JMI Blood Lancet
    • Safety Box
    • Copper T
  • Plant
    • QA/QC
    • Factory
    • Production
    • Engineering
  • Media
    • Video
    • News & Events
  • Contact
Home Shareholding Composition
Shareholding Position as on 30th June, 2024
A) Director & Sponsors:
SL No. Name of Director & Sponsors Share Qty % of Total Share
1 Md. Jabed Iqbal Pathan, Chairman 21,43,305 7.13%
2 Md. Abdur Razzaq, Managing Director 49,30,734 16.41%
3 Mr. Hoi Kwan Kim, Director 17,68,000 5.88%
Nipro Corporation, Director 1,50,96,000 50.23%
4 Mr. Kunio Takamido, Nominee Director of Nipro Corporation - 0.00%
5 Mr. Hiroki Furukawa, Nominee Director of Nipro Corporation - 0.00%
6 Mr. Hiroshi Saito, Nominee Director of Nipro Corporation - 0.00%
7 Mr. Seigo Tsuchiya, Nominee Director of Nipro Corporation - 0.00%
8 Mr. Hiromasa Wakatake, Nominee Director of Nipro Corporation - 0.00%
9 Mr. Kyoetsu Kobayashi, Nominee Director of Nipro Corporation - 0.00%
10 Mr. Yoshiharu Yonemori, Nominee Director of Nipro Corporation - 0.00%
11 Muhammod Mustafizur Rhman, Independent Director - 0.00%
12 A. T. M. Serajus Salekin, Independent Director - 0.00%
13 Md. Nazrul Islam, Independent Director - 0.00%
Total-A 2,39,38,039 79.64%
B) Shareholders holding 10% or more shares:
SL No. Name Share Qty % of Total Share
14 Nil 0 0.00%
Total-B Nil 0 0.00%
C) Corporate body / Institutions:
SL No. Name Share Qty % of Total Share
15 Institution Shareholders 13,24,029 4.41%
Total-C 13,24,029 4.41%
According to 1(5)(xxiii)(b) and (C) of Corporate governance, shareholding position of CEO, CS, CFO, HIA, Executives and companies, spouse and minor children, name wise should be disclose in the shareholding position. Please mention the name of CEO, CS, CFO, HIA and other key executives specifying the shareholding position in Annual Report
D) Key management:
SL No. Name Share Qty % of Total Share
16 Md. Abdur Razzaq, MD & CEO - Shown in Group-A
17 Muhammad Tarek Hossain Khan, Company Secretary 2,393 0.01%
18 Md. Abu Hana, CFO 878 0.00%
19 Md. Sohel Zaman, Head of Internal Audit - 0.00%
20 Md. Golam Mostafa, Director, Plant 1,546 0.01%
21 Md. Abu Jafor Chowdhury, Director, Procurement 2,26,650 0.75%
Total-D 2,31,467 0.77%
E) General Public Shareholders:
SL No. Name Share Qty % of Total Share
22 General Public Shareholders 45,62,465 15.18%
Total-E 45,62,465 15.18%
Grand Total (A+B+C+D+E): 3,00,56,000 100.00%

Headquarters

Unique Heights, Level-11, 117,
Kazi Nazrul Islam Avenue, Ramna,
Dhaka-1217, Bangladesh.

Tel : 880-2-55138723, 55138724

Fax : 880-2-55138725

E-Mail : info@jmigroup-bd.com

Quick Links

  • About Company
  • Major Highlight
  • Contact

Other Concerns

  • JMI GROUP
  • NIPRO JMI PHARMA
  • JMI VACCINE
Copyright © 2024 JMI Syringes & Medical Devices Limited .